| RS1696928123 |
OBSL1
|
Health Risk |
Likely pathogenic |
— |
| RS1696928201 |
PIKFYVE
|
Health Risk |
Likely pathogenic |
— |
| RS1696928206 |
ADAR
|
Health Risk |
Conflicting classifications of pathogenicity |
Symmetrical dyschromatosis of extremities, Aicardi-Goutieres syndrome 6 |
| RS1696930196 |
PNPT1
|
Health Risk |
Pathogenic |
Autosomal recessive nonsyndromic hearing loss 70, PNPT1-related disorder |
| RS1696976315 |
STT3B
|
Health Risk |
Pathogenic |
STT3B-congenital disorder of glycosylation, STT3B-congenital disorder of glycosylation |
| RS16969925 |
SCN1B
|
Health Risk |
Pathogenic/Likely pathogenic |
Atrial fibrillation, familial |
| RS16969926 |
SCN1B
|
Health Risk |
Conflicting classifications of pathogenicity |
Brugada syndrome 5, Brugada syndrome 5 |
| RS1697077852 |
TTN
|
Health Risk |
Likely pathogenic |
Cardiomyopathy, Dilated cardiomyopathy 1G |
| RS1697105934 |
TTN
|
Health Risk |
Likely pathogenic |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS1697127484 |
SCN1A
|
Health Risk |
Likely pathogenic |
Severe myoclonic epilepsy in infancy, Severe myoclonic epilepsy in infancy |
| RS1697134047 |
SCN1A
|
Health Risk |
Likely pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS1697138071 |
GLB1
|
Health Risk |
Likely pathogenic |
Mucopolysaccharidosis, MPS-IV-B |
| RS1697143129 |
GLB1
|
Health Risk |
Pathogenic |
— |
| RS1697157422 |
SCN1A
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, Developmental and epileptic encephalopathy |
| RS1697160366 |
SCN1A
|
Health Risk |
Pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS1697164036 |
SCN1A
|
Health Risk |
Pathogenic |
— |
| RS1697186082 |
SLC6A1
|
Health Risk |
Pathogenic |
Epilepsy with myoclonic atonic seizures, Epilepsy with myoclonic atonic seizures |
| RS1697194864 |
SLC6A1;SLC6A1-AS1
|
Health Risk |
Pathogenic |
— |
| RS1697195476 |
SLC6A1;SLC6A1-AS1
|
Health Risk |
Pathogenic |
— |
| RS1697195588 |
SLC6A1;SLC6A1-AS1
|
Health Risk |
Pathogenic |
— |
| RS1697195703 |
SLC6A1;SLC6A1-AS1
|
Health Risk |
Pathogenic |
— |
| RS1697197329 |
SLC6A1
|
Health Risk |
Likely pathogenic |
Neurodevelopmental delay, Neurodevelopmental delay |
| RS1697197599 |
SLC6A1
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Epilepsy with myoclonic atonic seizures |
| RS1697219158 |
WDPCP
|
Health Risk |
Conflicting classifications of pathogenicity |
Bardet-Biedl syndrome, Heart defect - tongue hamartoma - polysyndactyly syndrome |
| RS1697221045 |
SLC6A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Epilepsy with myoclonic atonic seizures, Epilepsy with myoclonic atonic seizures |
| RS1697221269 |
SCN2A
|
Health Risk |
Pathogenic/Likely pathogenic |
Inborn genetic diseases, Developmental and epileptic encephalopathy |
| RS1697224249 |
SLC6A1
|
Health Risk |
Pathogenic |
Epilepsy with myoclonic atonic seizures, Epilepsy with myoclonic atonic seizures |
| RS1697224468 |
SCN2A
|
Health Risk |
Pathogenic |
Intellectual disability, Developmental and epileptic encephalopathy |
| RS1697225194 |
MYO1B
|
Health Risk |
Pathogenic |
Colorectal cancer, Colorectal cancer |
| RS1697255114 |
GLB1
|
Health Risk |
Likely pathogenic |
Mucopolysaccharidosis, MPS-IV-B |
| RS1697260724 |
KLHL40
|
Health Risk |
Pathogenic |
Nemaline myopathy 8, Nemaline myopathy 8 |
| RS1697261615 |
SLC6A1
|
Health Risk |
Pathogenic |
Seizure, Seizure |
| RS1697263091 |
SLC6A1
|
Health Risk |
Pathogenic |
Epilepsy with myoclonic atonic seizures, Epilepsy with myoclonic atonic seizures |
| RS1697264007 |
SLC6A1
|
Health Risk |
Pathogenic/Likely pathogenic |
Intellectual disability, SLC6A1-related disorder |
| RS1697271674 |
SCN9A
|
Health Risk |
Pathogenic |
Neuropathy, hereditary sensory and autonomic |
| RS1697272149 |
SCN2A
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Developmental and epileptic encephalopathy |
| RS1697272829 |
SCN2A
|
Health Risk |
Likely pathogenic |
Complex neurodevelopmental disorder, Seizures |
| RS1697273920 |
SCN2A
|
Health Risk |
Likely pathogenic |
— |
| RS1697277352 |
SCN9A
|
Health Risk |
Pathogenic |
Neuropathy, hereditary sensory and autonomic |
| RS1697277384 |
SCN1A
|
Health Risk |
Pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS1697296215 |
SCN1A
|
Health Risk |
Conflicting classifications of pathogenicity |
SUDDEN INFANT DEATH SYNDROME, Inborn genetic diseases |
| RS1697297091 |
SCN1A
|
Health Risk |
Pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS1697309952 |
OBSL1
|
Health Risk |
Likely pathogenic |
— |
| RS1697311515 |
TTN
|
Health Risk |
Likely pathogenic |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS1697311700 |
SCN2A
|
Health Risk |
Pathogenic |
Complex neurodevelopmental disorder, Developmental and epileptic encephalopathy |
| RS1697317440 |
OBSL1
|
Health Risk |
Pathogenic |
— |
| RS1697319420 |
EDAR
|
Health Risk |
Likely pathogenic |
Ectodermal dysplasia 10A, hypohidrotic/hair/nail type |
| RS1697319878 |
KLHL40
|
Health Risk |
Pathogenic/Likely pathogenic |
Nemaline myopathy 8, Nemaline myopathy 8 |
| RS1697322263 |
EDAR
|
Health Risk |
Pathogenic |
Ectodermal dysplasia 10B, hypohidrotic/hair/tooth type |
| RS1697325895 |
SCN1A-AS1;SCN9A
|
Health Risk |
Pathogenic |
— |
| RS1697328487 |
SCN9A
|
Health Risk |
Likely pathogenic |
Neuropathy, hereditary sensory and autonomic |
| RS1697334156 |
GLB1
|
Health Risk |
Likely pathogenic |
GM1 gangliosidosis type 2, Infantile GM1 gangliosidosis |
| RS1697335361 |
GLB1
|
Health Risk |
Pathogenic/Likely pathogenic |
Mucopolysaccharidosis, MPS-IV-B |
| RS1697337518 |
SLC6A1
|
Health Risk |
Likely pathogenic |
Epilepsy with myoclonic atonic seizures, Epilepsy with myoclonic atonic seizures |
| RS1697337524 |
EDAR
|
Health Risk |
Conflicting classifications of pathogenicity |
Ectodermal dysplasia 10A, hypohidrotic/hair/nail type |
| RS1697338499 |
GLB1
|
Health Risk |
Pathogenic |
GM1 gangliosidosis, GM1 gangliosidosis |
| RS1697345011 |
UGT1A1
|
Health Risk |
Pathogenic |
UGT1A1-related disorder, UGT1A1-related disorder |
| RS1697360061 |
SCN2A
|
Health Risk |
Conflicting classifications of pathogenicity |
Complex neurodevelopmental disorder, Developmental and epileptic encephalopathy |
| RS1697361835 |
SCN2A
|
Health Risk |
Likely pathogenic |
— |
| RS1697364805 |
SCN2A
|
Health Risk |
Pathogenic/Likely pathogenic |
Developmental and epileptic encephalopathy, 11 |
| RS1697364931 |
SCN2A
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 11 |
| RS1697365096 |
TTN
|
Health Risk |
Likely pathogenic |
Cardiomyopathy, Cardiomyopathy |
| RS1697371244 |
ZNF142
|
Health Risk |
Pathogenic |
Neurodevelopmental disorder with impaired speech and hyperkinetic movements, Neurodevelopmental disorder with impaired speech and hyperkinetic movements |
| RS1697407694 |
PNPT1
|
Health Risk |
Likely pathogenic |
— |
| RS1697433995 |
SCN1A
|
Health Risk |
Likely pathogenic |
Migraine, familial hemiplegic |
| RS1697439559 |
SLC6A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Epilepsy with myoclonic atonic seizures, See cases |
| RS1697439746 |
SCN1A
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, Developmental and epileptic encephalopathy |
| RS1697440060 |
SCN1A
|
Health Risk |
Pathogenic |
Severe myoclonic epilepsy in infancy, Early-infantile DEE |
| RS1697441834 |
SCN1A
|
Health Risk |
Pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS1697443771 |
SLC6A1
|
Health Risk |
Pathogenic |
Intellectual disability, Intellectual disability |
| RS1697444014 |
SLC6A1
|
Health Risk |
Likely pathogenic |
Intellectual disability, Intellectual disability |
| RS1697444489 |
SLC6A1
|
Health Risk |
Pathogenic |
Epilepsy with myoclonic atonic seizures, Epilepsy with myoclonic atonic seizures |
| RS1697458345 |
SCN1A
|
Health Risk |
Pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS1697464108 |
SCN1A
|
Health Risk |
Pathogenic |
— |
| RS1697464755 |
SCN2A
|
Health Risk |
Pathogenic |
Seizures, benign familial infantile |
| RS1697465574 |
SCN2A
|
Health Risk |
Likely pathogenic |
— |
| RS1697473667 |
SCN1A
|
Health Risk |
Pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS1697477844 |
ZNF142
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS1697479557 |
SCN1A
|
Health Risk |
Conflicting classifications of pathogenicity |
Early-infantile DEE, Early-infantile DEE |
| RS1697532441 |
TTN
|
Health Risk |
Likely pathogenic |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS1697566111 |
SCN2A
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy, 11 |
| RS1697567984 |
SCN2A
|
Health Risk |
Likely pathogenic |
Inborn genetic diseases, Complex neurodevelopmental disorder |
| RS1697569199 |
SCN2A
|
Health Risk |
Pathogenic |
— |
| RS1697569337 |
SCN2A
|
Health Risk |
Pathogenic |
Seizures, benign familial infantile |
| RS1697578690 |
TTN
|
Health Risk |
Likely pathogenic |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS1697584614 |
SCN2A
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy, 11 |
| RS1697595705 |
TTN
|
Health Risk |
Pathogenic/Likely pathogenic |
Dilated cardiomyopathy 1A, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS1697605792 |
UGT1A1
|
Health Risk |
Pathogenic |
UGT1A1-related disorder, UGT1A1-related disorder |
| RS1697611007 |
ADAR
|
Health Risk |
Pathogenic |
— |
| RS1697632671 |
SCN1A
|
Health Risk |
Pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS1697640966 |
SCN1A
|
Health Risk |
Pathogenic |
— |
| RS1697645789 |
SCN1A
|
Health Risk |
Pathogenic |
Generalized epilepsy with febrile seizures plus, type 2 |
| RS1697647054 |
SCN1A
|
Health Risk |
Likely pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS1697657932 |
SCN9A
|
Health Risk |
Pathogenic |
Neuropathy, hereditary sensory and autonomic |
| RS1697667767 |
SCN1A
|
Health Risk |
Pathogenic |
Severe myoclonic epilepsy in infancy, Severe myoclonic epilepsy in infancy |
| RS1697674296 |
SCN1A
|
Health Risk |
Pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS1697695664 |
SCN2A
|
Health Risk |
Pathogenic |
Complex neurodevelopmental disorder, Complex neurodevelopmental disorder |
| RS1697702086 |
SCN2A
|
Health Risk |
Pathogenic |
Seizures, benign familial infantile |
| RS1697748409 |
SLC6A1
|
Health Risk |
Likely pathogenic |
Epilepsy with myoclonic atonic seizures, Epilepsy with myoclonic atonic seizures |
| RS1697771953 |
TRAF3IP1
|
Health Risk |
Likely pathogenic |
— |